About
EyeYon Medical is a commercial ophthalmic company dedicated to developing innovative medical devices for corneal diseases. Founded by ophthalmologists and industry experts, the company focuses on treating corneal edema and related conditions. Its flagship product, EndoArt®, is the world’s first synthetic implant designed as a safe alternative to traditional corneal transplantation, providing hope for patients with corneal blindness who cannot receive donor tissue. Additionally, EyeYon offers HyperCL™, a therapeutic contact lens that enhances drug absorption for more effective treatment of corneal conditions. The company aims to revolutionize corneal disease treatment by providing scalable solutions that reduce reliance on donor tissue and improve patient outcomes. EyeYon Medical has expanded its global presence with a subsidiary in China, addressing the needs of patients with corneal blindness in that market. The leadership team includes experienced professionals with extensive backgrounds in ophthalmology and healthcare, ensuring a strong foundation for the company's mission to improve the quality of life for patients worldwide.
Technologies
Keywords
Company Information
-
Employees 30
-
Founded 2011
-
Annual Revenue $6505000
-
Total Funding $35100000
Location
Ness Ziona, Center District, Israel
